Newpath Partners
VC · Boston · United States
Stages
Investment region
Industries
Profile
Newpath Partners is a venture capital firm based in Boston, Massachusetts, founded in 2018. The firm is led by physician-scientist Tom Cahill and focuses on forming companies from academic discoveries in gene editing and regenerative medicine. With a team of 6 professionals, Newpath Partners is dedicated to excellent science and forming strategic partnerships. The firm primarily invests in life sciences and healthcare sectors, with a focus on biotechnology, medtech, and digital health. They typically invest in Series A rounds, with check sizes ranging from $50,000 to $10 million. Newpath Partners invests mainly in the United States and has a strong track record of forming and exiting companies. Notable investments include Create Medicines - drug discovery, Leal Therapeutics - drug discovery, nChroma Bio - drug discovery, Metsera - drug discovery, and Autobahn Therapeutics - biotechnology.
Contatti (0)
No contacts on file.